RxDoctor Payments Data

David Wilson, MD

Retina Specialist · Portland, ORNPI 1316999642

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $4,563 of the $4,789 with a category attached, or 95.3%. Genentech, Inc. accounts for 93.5% of it on its own, with 2 other manufacturers making up the rest.

$4,789in general payments, 2019–2025

Across 7 payments — averaging $684.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Genentech, Inc.$4K
  • Johnson & Johnson Surgical Vision, Inc.$208
  • Alcon$101
$510,926in research payments, 2019–2025

Across 28 payments — averaging $18,247 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Sanofi US Services Inc.$493K
  • Genentech, Inc.$18K

What the payments were for

  • Consulting fees$4,56395%
  • Travel & lodging$1253%
  • Food & beverage$1012%

General payments by program year

19
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,789 in reported general payments places this provider in the 70th percentile of 36 retina specialist providers in Oregon.

See all retina specialist providers in Oregon

Medicare billing

Part B allowed, 2024
$3,134
Medicare patients
59
Services billed
111

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other retina specialist in Portland

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →